Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asia Spotlight: China’s New SFDA Chief Has A Public Health Background, And International Ties

Executive Summary

Vice Minister of Health Yin Li assumes post as director of China’s State FDA, taking the reigns from Shao Mingli, who led the agency since 2005.

You may also be interested in...



China's Center For Drug Evaluation Remakes Itself To Enter New Era Of Transparency, Speed Up Approvals

SHANGHAI - For years, China has talked about revising its drug review system to improve efficiency, and now major changes are in the works with China's State FDA reforming its drug review body, the Center for Drug Evaluation, to encourage drug innovation and facilitate globalization of its drug review process

With A/H1N1, A Spectre Is Haunting China: The Spectre Of SARS

BEIJING - As China's government mulls whether to galvanize a dozen vaccine producers across the country to turn out up to 300 million doses of an A/H1N1 defense and continues with the rapid-fire quarantine of anyone suspected of having contact with swine flu victims, health authorities are meeting with World Health Organization representatives to coordinate closely Beijing's response to the pandemic

China Executes Former Food And Drug Head

China executed Zheng Xiaouy, the former head of the State Food and Drug Administration, July 10 for dereliction of duty and for accepting $850,000 worth of bribes from pharmaceutical companies, according to the official Xinhua news service

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel